Cytodyn has been working hard. The amount of data

Cytodyn has been working hard. The amount of data and knowledge gained through various trials over the last year is remarkable. IMO Cytodyn knows what will make leronlimab look good in clinical trials for many diseases, the HIV BLA is getting done, and they know how to be resilient by having partners and manufacturing in multiple countries. There also will be great development efficiency over multiple diseases in having the biomarker and safety data from every trial added to their knowledge-base.

This is not an average biotech in it's business plan, and it isn't an average biotech pipeline. Both are far more substantive.

So here we are. The company's knowledge of its drug has matured to the point where IMO they know what will give them the data they need for the first few approvals if not more.

So IMO when you are on a team that is building something remarkably good, but a few loudmouths show up squawking hate directly as well as anonymously, and then you literally catch one trying to steal your Intellectual Property, you know what they are about. Nothing good.

I prefer to support those that are working to build something good.

There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.